dc.contributor.author | Maina Francis W. | |
dc.contributor.author | Sekadde-Kigondu C B. | |
dc.contributor.author | Ojwang PJ. | |
dc.contributor.author | Mati JK. | |
dc.date.accessioned | 2013-06-06T14:14:14Z | |
dc.date.available | 2013-06-06T14:14:14Z | |
dc.date.issued | 1987-07 | |
dc.identifier.citation | East Afr Med J. 1987 Jul;64(7):442-7. | en |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/pubmed/3691360 | |
dc.identifier.uri | http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/29435 | |
dc.description.abstract | 125 black Kenyan women attending the Kenyatta National Family Welfare Clinic were randomly allocated to combined and fixed dose oral contraceptives (Eugynon: 500 mcg dl-norgestrel + 50 mcg ethinyl estradiol or Microgynon: 150 mcg levonorgestel + 30 mcg ethinyl estradiol). They were between 18-33 years of age with a mean of 25 +or- 7 years. The mean parity of this group was 3 and they had a mean education standard of 8 years. Fasting blood sampled were taken on recruitment (control cycle) and thereafter once for cycles 1, 3, 6, 9, and 12 during OC use. HDL-cholesterol was estimated in the sear. The 2 OCs elicited a significant decrease in levels of HDL-cholesterol (p0.01). | en |
dc.language.iso | en | en |
dc.title | Changes in plasma HDL-cholesterol in women using oral contraceptives in Kenya | en |
dc.type | Article | en |